BP061

头孢氨苄

British Pharmacopoeia (BP) Reference Standard

• 别名: 7-(D-α-amino-phenylacetamido)-3-methyl-3-cepheme-4-carboxylic acid
• 经验公式（希尔记法）: C₁₆H₁₇N₃O₄S
• CAS号: 15686-71-2
• 分子量: 347.39
• EC號碼: 239-773-6
• MDL號碼: MFCD00056877
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: cefalexin
• 形狀: powder
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical; pharmaceutical small molecule
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: N[C@@H](C(N[C@@H]1C(N2[C@]1([H])SCC(C)=C2C(O)=O)=O)=O)C3=CC=CC=C3
• InChI: 1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
• InChI 密鑰: ZAIPMKNFIOOWCQ-UEKVPHQBSA-N

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Cefalexin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Cefalexin Oral Suspension

Cefalexin Capsules

Cefalexin Tablets

Cefradine Oral Suspension

Cefradine Capsules

Cefradine Injection

包裝

Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS08
• 訊號詞: Danger
• 危險聲明: H317,H334
• 防範說明: P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313
• 危險分類: Resp. Sens. 1 - Skin Sens. 1
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 1